SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing explosive price volatility driven by a massive short squeeze and concerns over extreme institutional concentration, fueling a heated debate between retail traders expecting a push toward quadruple digits and skeptics warning of a inevitable collapse. Investors are closely monitoring the stock's parabolic climb for signs of an impending secondary offering or regulatory intervention, as the community remains deeply divided over the sustainability of a rental car company trading at these valuations.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following a successful FCC grant of full commercial authority to deploy 223 additional satellites, a major milestone that clears critical regulatory hurdles for its U.S. direct-to-cell service expansion. Community sentiment is highly polarized, with retail investors discussing the potential for a massive short squeeze and long-term upside, while some bears express skepticism regarding launch timelines and operational risks despite the regulatory win.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intensified market volatility as investors weigh a substantial new share buyback program against recurring anxieties over AI-driven disruption in the creative software sector. While the community remains deeply divided, with many traders monitoring institutional moves from contrarian investors for signs of a bottom, discussions are heavily focused on whether Adobes cash-rich fundamentals and AI-integrated ecosystem can ultimately hold off emerging competitive threats.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing strong bullish momentum as investors shift focus toward its role in inference and CPU-driven AI workloads, while key analyst upgrades and institutional accumulation fuel speculation of a run toward higher price levels. Despite concerns about the stock's overextended structure and broader geopolitical risks impacting semiconductor supply chains, the community remains intensely focused on the stock's potential to break through current resistance and solidify its position in the AI infrastructure cycle.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume as investors react to a recent CFO interview that signaled scaling production and confirmed purchase orders from major industry players, effectively shifting the narrative from speculation to execution. The community is actively celebrating the move, which has fueled a short squeeze and strengthened sentiment as longs push back against recent critical reports.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing high volatility as the community intensely debates the impact of an indefinite ceasefire extension, with many traders labeling the move a manipulative "Taco Tuesday" tactic. Investors are closely monitoring the ongoing blockade of the Strait of Hormuz, as the persistence of supply constraints amidst shifting geopolitical headlines fuels skepticism regarding long-term market stability.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing a sharp surge driven by strong momentum, speculative short-squeeze activity, and heightened retail interest surrounding the company's role in the AI data center power infrastructure. While bulls are excited by the stock's parabolic technical breakout and potential institutional involvement, vocal skeptics remain focused on the firm's persistent negative earnings, high price-to-sales valuation, and significant short interest.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and community buzz following its acquisition of LivePerson, a move that is being framed by bulls as a strategic expansion into voice-messaging integration and enterprise-scale AI. While the acquisition has triggered debate regarding short-term dilution and potential profitability timelines, the community is actively tracking massive volume spikes and short-squeeze potential, with many investors viewing current price dips as accumulation opportunities while anticipating future growth from the combined entity's expanded Fortune 100 client base.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending following a strong quarterly earnings report that featured double-beat results driven by surging da Vinci surgical system placements and high procedure growth. Community members are actively debating the sustainability of the stock's massive after-hours pop, with long-term investors highlighting its durable competitive moat while some traders monitor valuation concerns and high price-to-earnings multiples.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to the upcoming presentation of preclinical data for its CDK9 inhibitor, SLS009, at the AACR conference, alongside persistent community debate over the timeline of its Phase 3 REGAL trial. Investors are actively discussing the potential for a buyout, comparing the company's valuation to recent sector acquisitions, while sentiment remains deeply polarized between those anticipating a major catalyst and those skeptical of trial progress.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Pharmaceutical Stocks Worth Watching - April 21st

Eli Lilly and Company, AbbVie, Novo Nordisk A/S, Abbott Laboratories, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical...

Abbott Laboratories (NYSE:ABT) Price Target Lowered to $135.00 at UBS Group

UBS Group decreased their price objective on shares of Abbott Laboratories from $158.00 to $135.00 and set a "buy" rating on the stock in a report on Monday...

Leerink Partners Lowers Abbott Laboratories (NYSE:ABT) Price Target to $106.00

Leerink Partners decreased their price target on Abbott Laboratories from $119.00 to $106.00 and set a "market perform" rating for the company in a research report on Tuesday...

Argus Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price

Argus decreased their price target on shares of Abbott Laboratories from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday...

Ticino Wealth Buys Shares of 11,005 Abbott Laboratories $ABT

Ticino Wealth bought a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 11,005 shares of the healthcare product maker's stock, valued...

Is the Options Market Predicting a Spike in Abbott Laboratories Stock?

Investors need to pay close attention to ABT stock based on the movements in the options market lately. 

Jones Kertz & Associates Inc. Buys New Stake in Abbott Laboratories $ABT

Jones Kertz & Associates Inc. bought a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange...

Rep. Laura Friedman  Shares of Abbott Laboratories (NYSE:ABT)

Representative Laura Friedman (Democratic-California) recently bought shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on April 17th, the Representative disclosed that they had bought between $1,001 and $15,000 in Abbott Laboratories stock on March 24th. The trade occurred in the Repr...

Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom

Key PointsAbbott Laboratories and Dexcom are the biggest players in the market for continuous glucose monitoring devices...

Pharmaceutical Stocks To Watch Now - April 20th

Eli Lilly and Company, AbbVie, Nektar Therapeutics, Abbott Laboratories, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and market prescri...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Max long

Hedged

Net short

All cash

Stocktwits

Stocktwits Polls

Long-term investors see a massive opportunity, citing strong cash flow and historically low valuations as reasons to accumulate.

Analysts and retail traders remain divided, with price targets ranging widely from the 80s to over 140 following recent research notes.

ABT
Abbott Laboratories

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ABT News

ABTAbbott Laboratories